Literature DB >> 20337511

Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China.

Zhongwei Jia1, Wei Wang, Christopher Dye, Yanping Bao, Zhimin Liu, Lin Lu.   

Abstract

BACKGROUND: A recent assessment by the Chinese government showed that sexual transmission is becoming the main mode of spreading human immunodeficiency virus (HIV) in China. The annual report on drug abuse demonstrated a seven-fold increase of use of Amphetamine Type Stimulants (ATS), which has been strongly correlated with sexual risk-taking behaviors, in 2007 than that in 2003. These observations suggest that ATS use may have contributed to the rapid increase in sexual transmission of HIV in China.
OBJECTIVE: The present study aims to investigate the potential association between new drug users and transmission modes.
METHODS: Partial Least Squares Path Model and Partial Least Squares Regression Models have been used to evaluate the potential correlation between ATS users and the sexual transmission of HIV.
RESULTS: Our analysis indicates that HIV infection by drug use mode mainly results from heroin users (R = .5). ATS (R = -.9) and other drug users (R = -.4) have a negative relationship with HIV infection by drug use mode. However, for HIV infection by sexual transmission mode, ATS (R = 5.5) and other drug users (R = .6) show a positive association. ATS, especially, presents a strongly association with the sexual transmission of HIV.
CONCLUSION: The study results suggest that ATS users significantly contribute to the sexual transmission of HIV. SCIENTIFIC SIGNIFICANCE: It is helpful to evaluate and predict the potential risk factors related with epidemic of HIV in China and provide theoretical evidence for HIV/AIDS health officers and policy makers to better construct target interventions and implement control measures.

Entities:  

Mesh:

Year:  2010        PMID: 20337511      PMCID: PMC5463739          DOI: 10.3109/00952991003734269

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  3 in total

1.  Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China.

Authors:  Susanne Y P Choi; Yuet Wah Cheung; Kanglin Chen
Journal:  Soc Sci Med       Date:  2005-09-26       Impact factor: 4.634

Review 2.  Rapid scale up of harm reduction in China.

Authors:  Sheena G Sullivan; Zunyou Wu
Journal:  Int J Drug Policy       Date:  2007-02-14

3.  Sexual behavior and risks for HIV infection and transmission among male injecting drug users in Yunnan, China.

Authors:  Yan Yao; Ning Wang; Jennifer Chu; Guowei Ding; Xia Jin; Yongli Sun; Guixiang Wang; Junjie Xu; Kumi Smith
Journal:  Int J Infect Dis       Date:  2008-09-07       Impact factor: 3.623

  3 in total
  5 in total

1.  Sexual risk behaviors among club drug users in Shanghai, China: prevalence and correlates.

Authors:  Yingying Ding; Na He; Weiming Zhu; Roger Detels
Journal:  AIDS Behav       Date:  2013-09

2.  Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China.

Authors:  Yingying Ding; Na He; Steven Shoptaw; Meiyang Gao; Roger Detels
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-29       Impact factor: 4.328

3.  Poppers use and risky sexual behaviors among men who have sex with men in Beijing, China.

Authors:  Heng Zhang; Tao Teng; Hongyan Lu; Yuejuan Zhao; Hongjie Liu; Lu Yin; Zheya Sun; Xiong He; Han-Zhu Qian; Yuhua Ruan; Yiming Shao; Sten H Vermund
Journal:  Drug Alcohol Depend       Date:  2015-12-10       Impact factor: 4.492

4.  Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.

Authors:  Allison J Applebaum; Jacqueline R Bullis; Lara N Traeger; Conall O'cleirigh; Michael W Otto; Mark H Pollack; Steven A Safren
Journal:  Neurobehav HIV Med       Date:  2010-08-10

5.  The influence of psychological variables on health-related quality of life among HIV-positive individuals with a history of intravenous drug use.

Authors:  Christina Psaros; Conall O'Cleirigh; Jacqueline R Bullis; Sarah M Markowitz; Steven A Safren
Journal:  J Psychoactive Drugs       Date:  2013 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.